In an adult who presents within 72 hours with acute peripheral facial nerve palsy consistent with Bell’s palsy and no identified alternative cause, what is the recommended first‑line treatment, including medication regimen and supportive measures?

Bell's Palsy Treatment

For adults presenting within 72 hours of acute peripheral facial nerve palsy consistent with Bell's palsy, prescribe oral corticosteroids immediately—either prednisolone 50 mg once daily for 10 days or prednisone 60 mg once daily for 5 days followed by a 5-day taper (reducing by 10 mg daily)—and implement aggressive eye protection measures. 1

Corticosteroid Therapy: The Cornerstone of Treatment

Initiate oral corticosteroids within 72 hours of symptom onset; treatment started after this window provides no benefit. 1

Recommended Regimens

• Option 1: Prednisolone 50 mg once daily for 10 days (no taper required) 1
• Option 2: Prednisone 60 mg once daily for 5 days, then taper by 10 mg daily (50→40→30→20→10 mg) over the next 5 days, stopping on day 11 1

Evidence Supporting Corticosteroids

• 83% of patients achieve complete recovery at 3 months with prednisolone versus 63.6% with placebo (absolute benefit 19.4%; NNT = 6) 1
• 94.4% achieve complete recovery at 9 months with prednisolone versus 81.6% with placebo (absolute benefit 12.8%; NNT = 8) 1
• This represents the highest-quality evidence (Level A) from randomized controlled trials and is a strong recommendation from the American Academy of Otolaryngology-Head and Neck Surgery 1, 2

Common Pitfall: Inadequate Dosing

• A standard methylprednisolone dose pack delivers only ~105 mg prednisone-equivalent over 6 days, far below the required ~540 mg total exposure needed for effective treatment—this represents significant underdosing and should be avoided 1

Antiviral Therapy: Optional Adjunct Only

Antiviral monotherapy is never appropriate and should never be prescribed alone for Bell's palsy. 1, 3

When to Consider Adding Antivirals

• Combination therapy (corticosteroids + antiviral) may be offered within 72 hours for severe or complete paralysis, though the added benefit is modest 1
• Valacyclovir 1000 mg three times daily for 7 days OR acyclovir 400 mg five times daily for 10 days can be added to steroids 1
• Evidence shows 96.5% complete recovery with combination therapy versus 89.7% with steroids alone (absolute benefit 6.8%)—a small incremental gain classified as an "option" rather than a formal recommendation 1
• The large BELLS trial (n=496) found no statistically significant advantage of adding acyclovir: 71.2% recovery with acyclovir versus 75.7% without (P=0.50) at 3 months 1

Eye Protection: Mandatory for All Patients with Incomplete Eye Closure

Implement comprehensive eye protection immediately to prevent permanent corneal damage—this is a strong recommendation with preponderance of benefit over harm. 1

Daytime Protection

• Lubricating ophthalmic drops (e.g., hydroxypropyl methylcellulose) every 1–2 hours while awake 1
• Sunglasses outdoors to shield against wind, debris, and foreign particles 1

Nighttime Protection

• Ophthalmic ointment (e.g., dexpanthenol) at bedtime for sustained moisture retention 1, 4
• Eye taping or patching at night with careful instruction on proper technique to avoid corneal abrasion 1
• Moisture chambers using polyethylene covers for severe cases 1

Urgent Ophthalmology Referral Triggers

• Severe impairment with complete inability to close the eye 1
• Eye pain, vision changes, redness, discharge, foreign body sensation, or increasing irritation despite protection measures 1

Diagnostic Testing: What NOT to Do

Do not order routine laboratory tests or imaging for typical Bell's palsy presentations—these delay treatment beyond the critical 72-hour window without improving outcomes. 1, 5

Testing to Avoid

• No routine blood work (CBC, metabolic panel, viral serologies) 1
• No routine CT or MRI for classic presentations 1, 5
• No electrodiagnostic testing for patients with incomplete facial paralysis 1

When Imaging IS Indicated (Red Flags)

Order MRI with and without contrast if any of the following are present: 1, 5

• Recurrent paralysis on the same side
• Bilateral facial weakness
• Isolated branch paralysis (e.g., only lower face affected)
• Involvement of other cranial nerves
• Progressive weakness beyond 3 weeks
• No recovery after 3 months
• History of head/neck malignancy or parotid tumor
• Recent head trauma or temporal bone fracture

Confirming the Diagnosis: Key Clinical Features

Must Be Present

• Acute onset within 72 hours (rapid progression to maximal weakness) 1, 6
• Unilateral facial weakness involving the forehead (ability to wrinkle forehead distinguishes peripheral from central stroke) 1, 6
• No other neurologic deficits (limb weakness, speech changes, altered mental status, or other cranial nerve involvement excludes Bell's palsy) 1, 5

Supportive Features (Not Required but Common)

• Ipsilateral ear or facial pain 5, 6
• Hyperacusis (increased sound sensitivity) 5, 6
• Taste disturbance on anterior two-thirds of tongue 5, 6
• Dry eye or excessive tearing 5, 6
• Recent viral upper respiratory infection 5

Follow-Up and Referral Triggers

Mandatory Reassessment at 3 Months

• Refer to a facial nerve specialist if recovery is incomplete at 3 months after symptom onset 1, 6

Urgent Referral at Any Time Point

• New or worsening neurologic findings (suggests alternative diagnosis such as tumor or stroke) 1, 6
• Development of ocular symptoms (requires ophthalmology evaluation to prevent corneal damage) 1, 6

Early Follow-Up (1–2 Weeks)

• Assess recovery trajectory 1
• Reinforce eye protection techniques 1
• Identify early complications 1

Special Populations

Diabetes

• Diabetes is NOT a contraindication to corticosteroids—the therapeutic benefit outweighs the risk of temporary hyperglycemia 1
• Monitor capillary blood glucose every 2–4 hours during the first few days of steroid therapy 1
• Proactively increase basal and prandial insulin doses; consider adding NPH insulin concurrent with morning steroid dose (peaks 4–6 hours later, matching hyperglycemic effect) 1

Pregnancy

• Pregnant women should be treated with oral corticosteroids within 72 hours after individualized risk-benefit assessment 1
• Eye protection measures are essential and safe in pregnancy 1

Children

• Children have better prognosis with higher rates of spontaneous recovery than adults 1
• Evidence for corticosteroid benefit in children is inconclusive—treatment decisions should involve substantial caregiver participation in shared decision-making 1
• If treating, use prednisolone 1 mg/kg/day (maximum 50–60 mg) for 5 days followed by a 5-day taper 1

Interventions NOT Recommended

• Physical therapy: No proven benefit over spontaneous recovery 1, 7
• Acupuncture: Poor-quality trials with indeterminate benefit-harm ratio 1, 7
• Surgical decompression: Not advised except in rare, highly selected cases at specialized centers 1, 3, 4

Prognosis

• Patients with incomplete paralysis: Up to 94% complete recovery 1, 6
• Patients with complete paralysis: Approximately 70% complete recovery within 6 months 1, 6
• Most patients begin showing recovery within 2–3 weeks, with complete recovery typically occurring within 3–4 months 1, 6
• 30% may experience permanent facial weakness with muscle contractures, requiring long-term management including potential reconstructive surgery 1, 6